Type 2 Diabetes study: Standard Aerobic Training
Official title Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
ClinicalTrials.gov ID: NCT07196371
What this study is testing
- What it's testing
- The study will see if adding blood‑flow restriction to treadmill walking is doable and if it improves fitness and blood sugar control compared to walking alone.
- Who it's for
- Adults who have type 2 diabetes and can walk on a treadmill.
- What's involved
- Participants will walk on a treadmill for about 96 minutes each week for 6 weeks, either with or without a cuff that limits blood flow. They will visit the lab before and after the program for tests and questionnaires.
- Time commitment
- The program lasts 6 weeks, with weekly treadmill sessions and two lab visits (start and finish).
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 64
You may be able to join if
- Diagnosed with type 2 diabetes (5.7% \< HbA1c \< 9.0%)
- Not regularly physically active (150 mins moderate-vigorous physical activity per week)
You likely can't join if
- Musculoskeletal issues preventing exercise training
- Unstable medications over the last 3 months
- Absolute contraindications to BFR (i.e. peripheral vascular disease)
- A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions
- A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis)
- Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely
See the full eligibility criteria
- Diagnosed with type 2 diabetes (5.7% \< HbA1c \< 9.0%)
- Not regularly physically active (150 mins moderate-vigorous physical activity per week)
- Musculoskeletal issues preventing exercise training
- Unstable medications over the last 3 months
- Absolute contraindications to BFR (i.e. peripheral vascular disease)
- A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions
- A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis)
- Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely
- Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity
The study team makes the final eligibility decision.
Where it is enrolling
- Fredericton, New Brunswick, Canada
- Guelph, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Fredericton, New Brunswick, Canada; Guelph, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.